Share Twitter LinkedIn Facebook Email Jesus Berdeja, MD of Sarah Cannon Research Institute discusses the BCMA CAR-T therapy JNJ-4528 in pretreated patients with multiple myeloma. Read here: https://meetinglibrary.asco.org/record/186155/abstract Advertisement